Michael R. Christensen is a partner in the Medical Device group at Knobbe Martens. While he has helped clients protect a variety of technologies, the majority of his practice focuses on protecting innovation and building patent portfolios for startup medical device clients. The technologies of some representative clients include MRI-compatible infusion pumps and novel devices and therapies for the treatment of stroke, diabetes, atrial fibrillation and back pain.
Mr. Christensen also has extensive experience conducting patent due diligence for leading Venture Capital firms and performing IP audits for companies seeking to identify ways to improve their patent portfolios. One of Mr. Christensen’s areas of expertise is developing strategies for expediting patent prosecution, both in the United States and abroad.
In his presentation, Michael will review the key steps to successful IP filings, reviewing provisional patents, utility patents, the Patent Cooperation Treaty (PCT), and Fast Track US filings.
Legal Disclaimer
The information provided on this page and in this podcast series does not constitute legal advice. All information is for general informational purposes only and may not constitute the most up-to-date legal or other information. Users are encouraged to contact their attorney to obtain advice with respect to any particular legal matter. Users are not advised to act or refrain from acting on the basis of information found herein without first seeking legal advice from counsel in their jurisdiction. Only your own attorney can provide assurances that the information contained herein is applicable or appropriate to your particular situation. Using the information on this site or listening to this podcast series does not create an attorney-client relationship between the user and the presenters or their law firms. The views expressed herein are those of the individual presenters in their individual capacities only—not those of their firms or IEEE. All liability with respect to actions taken or not taken based on the contents of this webpage and podcast series are hereby expressly disclaimed. The content on this page is provided “as is.” No representations are made that the content is error-free.